1
|
|
2
|
Elgeddawy SA, Shaheen HM, El-Sayed YS, Abd Elaziz M, Darwish A, Samak D, Batiha GE, Mady RA, Bin-Jumah M, Allam AA, Alagawany M, Taha AE, El-Mleeh A, El-Sayed SAA, Abd El-Hack ME, Elnesr SS. Effects of the dietary inclusion of a probiotic or prebiotic on florfenicol pharmacokinetic profile in broiler chicken. J Anim Physiol Anim Nutr (Berl) 2020; 104:549-557. [PMID: 32017274 DOI: 10.1111/jpn.13317] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2019] [Revised: 12/24/2019] [Accepted: 01/09/2020] [Indexed: 12/14/2022]
Abstract
We evaluated the effect of prebiotic or probiotic as feed additives on florfenicol kinetic in broilers feed. Unsexed two hundred, thirty-five-day-old broiler chickens, were put in four equal groups (n = 50). The first group was administrated florfenicol intravenous at 30 mg/kg body weight (BW) only once dosage without pre- or probiotic administration to determine the bioavailability. While, the second group was administrated florfenicol (intracrop routes; a dosage of 30 mg/kg BW for five progressive days) without pre- or probiotic co-administration. The third and the fourth groups were administrated the same dose of florfenicol (intracrop route) for five successive days, followed by 10 days of prebiotic or probiotic treatment respectively. The plasma florfenicol % was identified by high-pressure liquid chromatography (HPLC) after the first florfenicol administration (intravenous or intracrop routes) in all groups. Then, the residual levels of florfenicol were determined in liver, kidney and muscle tissues from the second, third and fourth groups which were exposed to florfenicol orally. Our results demonstrated that broilers pre-treated with prebiotic or probiotic significantly increased Cmax , AUC0- t , AUC0-inf as well as AUMC values, while significant drop was recorded in V/F and CL/F. Prebiotic or probiotic influenced the cumulative effect of florfenicol in liver and kidney tissues of treated birds.
Collapse
Affiliation(s)
- Samy A Elgeddawy
- Unit of Pharmacology, Department of Chemistry, Animal Health Research Institute, Giza, Egypt
| | - Hazem M Shaheen
- Department of Pharmacology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt
| | - Yasser S El-Sayed
- Department of Veterinary Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt
| | - Magdy Abd Elaziz
- Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Damanhour, Egypt
| | - Ashraf Darwish
- Unit of Pharmacology, Department of Chemistry, Animal Health Research Institute, Giza, Egypt
| | - Dalia Samak
- Department of Veterinary Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt
| | - Gaber E Batiha
- Department of Pharmacology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt
| | - Rehab A Mady
- Department of Pharmacology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt
| | - May Bin-Jumah
- Biology Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
| | - Ahmed A Allam
- Department of Zoology, Faculty of Science, Beni-suef University, Beni-suef, Egypt
| | - Mahmoud Alagawany
- Department of Poultry, Faculty of Agriculture, Zagazig University, Zagazig, Egypt
| | - Ayman E Taha
- Department of Animal Husbandry and Animal Wealth Development, Faculty of Veterinary Medicine, Alexandria University, Edfina, Egypt
| | - Amany El-Mleeh
- Department of Pharmacology, Faculty of Veterinary Medicine, Menoufia University, Menoufia, Egypt
| | - Sabry A A El-Sayed
- Department of Nutrition and Clinical Nutrition, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt
| | | | - Shaaban S Elnesr
- Department of Poultry Production, Faculty of Agriculture, Fayoum University, Fayoum, Egypt
| |
Collapse
|
3
|
Altan F, Sayin Ipek DN, Corum O, Yesilmen Alp S, Ipek P, Uney K. The effects of Mannheimia haemolytica and albendazole on marbofloxacin pharmacokinetics in lambs. Trop Anim Health Prod 2019; 51:2603-2610. [PMID: 31230255 DOI: 10.1007/s11250-019-01980-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2018] [Accepted: 06/12/2019] [Indexed: 11/28/2022]
Abstract
The study aimed to define the effects of M. haemolytica and a single oral dose of albendazole on the single-dose pharmacokinetics of marbofloxacin in lambs. The pharmacokinetic-pharmacodynamic integration of marbofloxacin was applied to describe a 3 mg/kg intramuscular dose in lambs. The 6 healthy and 12 naturally infected with M. haemolytica lambs (Akkaraman, males weighing 10-15 kg and aged 2-3 months) were used in this study. In the marbofloxacin group, 6 healthy lambs received marbofloxacin. In the albendazole group after 2 weeks washout period, the same animals received marbofloxacin on 1 h after albendazole. In the diseased marbofloxacin group, 6 lambs naturally infected with M. haemolytica received marbofloxacin. In the diseased albendazole group, 6 lambs naturally infected with M. haemolytica received marbofloxacin on 1 h after albendazole. The marbofloxacin and albendazole were administered each as a single dose of 3 mg/kg intramuscular and 7.5 mg/kg oral, respectively, in the respective groups. Plasma concentration of marbofloxacin was measured with HPLC-UV and pharmacokinetic parameters were analyzed by non-compartmental model. Albendazole did not change the pharmacokinetic profiles of marbofloxacin in healthy and diseased lambs. However, M. haemolytica affected the pharmacokinetics of marbofloxacin in diseased lambs, AUC0-24/MIC90 ratio was not found to be higher than 125, but Cmax/MIC90 ratios was found to be higher than 10 for an MIC value of 0.25 μg/mL in all groups. The marbofloxacin dose described in this study may not be effective for the treatment of infections due to M. haemolytica in lambs, with MIC ≤ 0.25 μg/mL.
Collapse
Affiliation(s)
- Feray Altan
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Dicle, Diyarbakir, Turkey.
| | - Duygu Neval Sayin Ipek
- Department of Parasitology, Faculty of Veterinary Medicine, University of Dicle, Diyarbakir, Turkey
| | - Orhan Corum
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Kastamonu, Kastamonu, Turkey
| | - Simten Yesilmen Alp
- Department of Microbiology, Faculty of Veterinary Medicine, University of Dicle, Diyarbakir, Turkey
| | - Polat Ipek
- Department of Physiology, Faculty of Veterinary Medicine, University of Dicle, Diyarbakir, Turkey
| | - Kamil Uney
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkey
| |
Collapse
|
4
|
Martin KL, Clapham MO, Davis JL, Baynes RE, Lin Z, Vickroy TW, Riviere JE, Tell LA. Extralabel drug use in small ruminants. J Am Vet Med Assoc 2019; 253:1001-1009. [PMID: 30272520 DOI: 10.2460/javma.253.8.1001] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
5
|
Yang F, Lin Z, Riviere JE, Baynes RE. Development and application of a population physiologically based pharmacokinetic model for florfenicol and its metabolite florfenicol amine in cattle. Food Chem Toxicol 2019; 126:285-294. [DOI: 10.1016/j.fct.2019.02.029] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Revised: 02/14/2019] [Accepted: 02/19/2019] [Indexed: 12/17/2022]
|
6
|
Chang KC, Tsai CE. Bioequivalence evaluation of Florfenicol pharmaceutics in pigs using liquid chromatography-tandem mass spectrometry. J LIQ CHROMATOGR R T 2018. [DOI: 10.1080/10826076.2018.1448869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Affiliation(s)
- Kai-Chun Chang
- Division of Animal Industry, Agricultural Technology Research Institute, Miaoli, Taiwan, ROC
| | - Chin-En Tsai
- Department of Veterinary Medicine, College of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan, ROC
| |
Collapse
|
7
|
Xu Y, Wen X, Feng X, Liang Z, Ye X, Nie H, Liao X, Li J, Zeng Y, Tang S, He J. Preparation, characterization, and pharmacokinetics in swine of a florfenicol enteric formulation prepared using hot-melt extrusion technology. J Vet Pharmacol Ther 2018; 41:572-580. [PMID: 29500829 DOI: 10.1111/jvp.12498] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2017] [Accepted: 02/08/2018] [Indexed: 11/29/2022]
Abstract
The objective of this work was to manufacture an enteric formulation of florfenicol (FF) using hot-melt extrusion (HME) technology and to evaluate its in vitro dissolution and in vivo pharmacokinetics. For the HME process, hypromellose acetate succinate LG (HPMCAS-LG) was the enteric polymer mixed with FF, and the two components were extruded with a standard screw configuration at a speed of 50 rpm. Differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), powder X-ray diffraction (PXRD), and Fourier transform infrared spectroscopy (FT-IR) were performed to characterize the HME extrudate. The release percentage of the enteric formulation in the acidic stage was <10% of the loaded FF, whereas that in the phosphate buffer stage was >80%. Pharmacokinetic evaluations in swine revealed that the enteric formulation had a longer t1/2λ and MRT than commercially available FF powder (FULAIKA® ), indicating that the novel formulation exhibited enteric and sustained release properties. Compared with the commercial product, the relative bioavailability of the enteric formulation reached up to 117.2%. This study suggests that this formulation may have potential for future commercialization.
Collapse
Affiliation(s)
- Y Xu
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - X Wen
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - X Feng
- The Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, Oxford, MS, USA
| | - Z Liang
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - X Ye
- The Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, Oxford, MS, USA
| | - H Nie
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - X Liao
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - J Li
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - Y Zeng
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| | - S Tang
- The Department of Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China
| | - J He
- College of Animal Science and Technology, Guangxi University, Nanning, Guangxi, China
| |
Collapse
|
8
|
Pawluk SA, Roels CA, Wilby KJ, Ensom MHH. A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole. Clin Pharmacokinet 2015; 54:371-83. [PMID: 25691367 DOI: 10.1007/s40262-015-0243-9] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Medications indicated for helminthes and other parasitic infections are frequently being used in mass populations in endemic areas. Currently, there is a lack of guidance for clinicians on how to appropriately manage drug interactions when faced with patients requiring short-term anthelmintic therapy with albendazole or mebendazole while concurrently taking other agents. The objective of this review was to systematically summarize and evaluate published literature on the pharmacokinetics of albendazole or mebendazole when taken with other interacting medications. A search of MEDLINE (1946 to October 2014), EMBASE (1974 to October 2014), International Pharmaceutical Abstracts (1970 to October 2014), Google, and Google Scholar was conducted for articles describing the pharmacokinetics of albendazole or mebendazole when given with other medications (and supplemented by a bibliographic review of all relevant articles). Altogether, 17 articles were included in the review. Studies reported data on pharmacokinetic parameters for albendazole or mebendazole when taken with cimetidine, dexamethasone, ritonavir, phenytoin, carbamazepine, phenobarbital, ivermectin, praziquantel, diethylcarbamazine, azithromycin, and levamisole. Cimetidine increased the elimination half-life of albendazole and maximum concentration (Cmax) of mebendazole; dexamethasone increased the area under the plasma concentration-time curve (AUC) of albendazole; levamisole decreased the Cmax of albendazole; anticonvulsants (phenytoin, phenobarbital, carbamazepine) decreased the AUC of albendazole; praziquantel increased the AUC of albendazole; and ritonavir decreased the AUC of both albendazole and mebendazole. No major interactions were found with ivermectin, azithromycin, or diethylcarbamazine. Future research is required to clarify the clinical relevance of the interactions observed.
Collapse
|
9
|
|
10
|
Power C, Sayers R, Danaher M, Moloney M, O'Brien B, Furey A, Jordan K. Investigation of the persistence of florfenicol residues in bovine milk and fate during processing. Int Dairy J 2014. [DOI: 10.1016/j.idairyj.2014.07.012] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
11
|
Liu C, Wang SJ, Zhang Q, Shao YX. Influence of three coccidiostats on the pharmacokinetics of florfenicol in rabbits. Exp Anim 2014; 64:73-9. [PMID: 25319758 PMCID: PMC4329518 DOI: 10.1538/expanim.14-0064] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
In-feed Medication has been used for a long time to prevent coccidiosis, a worldwide
protozoal disease in rabbits. Florfenicol (FFC) has been widely used in veterinary clinics
for bacterial diseases treatment. Therefore, the use of combinations of coccidiostats with
FFC in rabbits is common. In the present study, we aimed to evaluate the effect of three
coccidiostats, sulfaquinoxaline (SUL), robenidine (ROB), and toltrazuril (TOL), as feed
additives on the pharmacokinetic profile of FFC in rabbits. The disposition kinetics of
FFC in rabbits were investigated after a single intravenous injection (25 mg/kg) in
rabbits fed anticoccidial-free diets or feeds containing SUL (250 ppm), ROB (66 ppm), or
TOL (2 ppm), respectively, for 20 days. Plasma FFC concentrations were determined by the
high performance liquid chromatography (HPLC) method. The pharmacokinetic parameters of
FFC were analyzed using a non-compartmental analysis based on the statistical moment
theory. The results demonstrated that ROB feeding resulted in an obvious decrease in
plasma FFC level as compared with anticoccidial-free feeding. The terminal elimination
half-life (t1/2z), area under the concentration–time curve
(AUC), area under the first moment curve (AUMC), and
mean residence time (MRT) significantly decreased, whereas the
elimination rate constant (λz) and total body clearance
(CLz) obviously increased in rabbits pretreated with ROB.
However, we did not find that SUL or TOL feeding had any effect on the pharmacokinetic
profile of FFC. Our findings suggested that more attention should be paid to the use of
FFC in rabbits supplemented with ROB.
Collapse
Affiliation(s)
- Chun Liu
- Laboratory Animal Center, Nantong University, Nantong, P.R. China
| | | | | | | |
Collapse
|
12
|
Ding F, Peng W, Peng YK, Jiang YT. Renal protein reactivity and stability of antibiotic amphenicols: structure and affinity. MOLECULAR BIOSYSTEMS 2014; 10:2509-16. [PMID: 25016933 DOI: 10.1039/c4mb00220b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
In the present work, the molecular recognition of the oldest active amphenicols by the most popular renal carrier, lysozyme, was deciphered by using fluorescence, circular dichroism (CD) and molecular modeling at the molecular scale. Steady state fluorescence data showed that the recognition of amphenicol by lysozyme yields a static type of fluorescence quenching. This corroborates time-resolved fluorescence results that lysozyme-amphenicol adduct formation has a moderate affinity of 10(4) M(-1), and the driving forces were found to be chiefly hydrogen bonds, hydrophobic interactions and π stacking. Far-UV CD spectra confirmed that the spatial structure of lysozyme was slightly changed with a distinct reduction of α-helices in the presence of amphenicol, suggesting partial destabilization of the protein. Furthermore, via the extrinsic 8-anilino-1-naphthalenesulfonic acid fluorescence spectral properties and molecular modeling, one could see that the amphenicol binding site was situated at the deep crevice on the protein surface, and the ligand was also near to several crucial amino acid residues, such as Trp-62, Trp-63 and Arg-73. Simultaneously, contrastive studies of protein-amphenicols revealed clearly that some substituting groups, e.g. nitryl in the molecular structure of ligands, may be vitally important for the recognition activity of amphenicols with lysozyme. Due to the connection of amphenicols with fatal detrimental effects and because lysozyme has been applied as a drug carrier for proximal tubular targeting, the discussion herein is necessary for rational antibiotic use, development of safe antibiotics and particularly a better appraisal of the risks associated with human exposure to toxic agrochemicals.
Collapse
Affiliation(s)
- Fei Ding
- College of Food Science & Engineering, Northwest A&F University, Yangling 712100, China.
| | | | | | | |
Collapse
|
13
|
Martins A, Guimarães L, Guilhermino L. Chronic toxicity of the veterinary antibiotic florfenicol to Daphnia magna assessed at two temperatures. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2013; 36:1022-32. [PMID: 24096010 DOI: 10.1016/j.etap.2013.09.001] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2013] [Revised: 08/04/2013] [Accepted: 09/04/2013] [Indexed: 05/07/2023]
Abstract
The hypothesis that temperature variation is able to modify the chronic toxicity of the antibiotic florfenicol (FLO) to Daphnia magna was tested in the present study. Twenty-one day laboratory bioassays were carried out at 20 and 25 °C. FLO concentrations and its potential decay during the assays were checked by spectrophotometry. At 20 °C, FLO significantly reduced the D. magna somatic growth (≥1.6 mg/L) and impaired its reproduction (EC₂₀=6.9 mg/L; EC₅₀=7.6 mg/L), with the population growth rate becoming negative at 12.6 mg/L. At 25 °C, the EC values were lower (1.7 and 1.9 mg/L, respectively) than at 20 °C, as well as the lowest exposure concentration causing a negative population growth rate (3.1 mg/L). These results clearly indicate that temperature raise from 20 to 25 °C was able to modify the FLO toxicity. Therefore, more studies on the combined effects of temperature changes and environmental contaminants are needed to improve the basis for ecological risk assessment, environmental and human safety.
Collapse
Affiliation(s)
- Alexandra Martins
- ICBAS - Institute of Biomedical Sciences of Abel Salazar, Department of Populations Studies, Laboratory of Ecotoxicology, University of Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; CIIMAR/CIMAR - Interdisciplinary Centre of Marine and Environmental Research, Laboratory of Ecotoxicology and Ecology, University of Porto, Rua dos Bragas, 289, 4050-123 Porto, Portugal.
| | | | | |
Collapse
|
14
|
Kandeel M, Elgazar W, Kitade Y. The Binding Interactions of the Macrolide Endectocide Ivermectin with the Antibiotics Ampicillin, Chloramphenicol and Tetracycline HCL. Indian J Pharm Sci 2013; 74:592-6. [PMID: 23798790 PMCID: PMC3687934 DOI: 10.4103/0250-474x.110635] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2011] [Revised: 12/11/2012] [Accepted: 12/22/2012] [Indexed: 12/26/2022] Open
Abstract
Ivermectin, chloramphenicol, ampicillin and tetracycline HCl are common drugs in human and veterinary practice. The purpose of this study is to investigate the possible binding interactions between ivermectin and the antibiotics chloramphenicol, ampicillin and tetracycline HCl. Isothermal titration calorimetry was used to determine the binding interactions between ivermectin and these antibiotics. Results indicated that, about three molecules of ampicillin can bind to one molecule of ivermectin and about one molecule of chloramphenicol with one molecule of ivermectin. However, no binding stoichiometry can be detected with tetracycline HCl-ivermectin titration. Furthermore, the binding interactions were accompanied by various biophysical and biochemical mechanisms. This is the first report of such interactions of ivermectin with chloramphenicol, ampicillin and tetracycline HCl. There are possible binding interactions of ivermectin with chloramphenicol and ampicillin. Further studies are required for detecting the impact of this binding on biological aspects of drug actions.
Collapse
Affiliation(s)
- M Kandeel
- United Graduate School of Drug Discovery and Medical Information Sciences,Gifu University, Yanagido 1-1, Gifu 501-1193, Japan
| | | | | |
Collapse
|